Low-dose CT screening for lung cancer is recommended for certain individuals, but two new studies highlight some of the limitations and growing pains of a screening program.
The steep increase in thyroid cancer diagnosis has not been mirrored by increasing mortality rates and is likely due to widespread overdiagnosis of small neoplasms.
Relapsed or refractory multiple myeloma patients experience high response rates, overall survival with bortezomib-based therapy.
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis.
A 27-year-old woman presents with chest pain, cough, and general malaise. Imaging reveals an anterior mediastinal mass. What is your diagnosis?
DLBCL and FL patients experience considerable economic burden during the first year after diagnosis.
Patients treated with anti–PD-1 or anti–PD-L1 inhibitors in clinical trials were successfully retreated with the inhibitors after discontinuing the treatment.
The combination of obinutuzumab and lenalidomide was found to be effective in relapsed or refractory follicular B-cell lymphoma.
A high level of resilience was associated with a better mental and physical health-related quality of life among patients with multiple myeloma.
The survival advantages associated with NCCN guideline–driven care were not realized in younger patients with stage II and stage III rectal cancer.